Cipla Limited
CIPLA
Classement en actions
#1816
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Prix de l'action
$14.61
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$11.80B
Changement (1 jour)
-0.12%
Changement (1 an)
-21.66%
Pays
IN
Échange Cipla Limited (CIPLA)
Catégorie
Healthcare
Historique du rendement du dividende pour Cipla Limited (CIPLA)
Le rendement du dividende (TTM) de Cipla Limited (symbole boursier : CIPLA) au 2024-03-31 est : 0.57%
Rendement moyen du dividende sur les 5 dernières années : 0.50%
Rendement moyen du dividende sur les 5 dernières années : 0.50%
Historique du rendement du dividende de Cipla Limited (CIPLA) de 2004 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 0.98% | 8.89% |
| 2025 | 0.90% | 57.89% |
| 2024 | 0.57% | 1.79% |
| 2023 | 0.56% | 14.29% |
| 2022 | 0.49% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 1.66% | 191.23% |
| 2019 | 0.57% | 62.86% |
| 2018 | 0.35% | 2.94% |
| 2017 | 0.34% | -12.82% |
| 2016 | 0.39% | 39.29% |
| 2015 | 0.28% | -46.15% |
| 2014 | 0.52% | 0.00% |
| 2013 | 0.52% | -21.21% |
| 2012 | 0.66% | -24.14% |
| 2011 | 0.87% | 50.00% |
| 2010 | 0.58% | -36.26% |
| 2009 | 0.91% | 0.00% |
| 2008 | 0.91% | 7.06% |
| 2007 | 0.85% | 60.38% |
| 2006 | 0.53% | -54.70% |
| 2005 | 1.17% | 37.65% |
| 2004 | 0.85% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
